Guillain-Barré Syndrome cases. President Dina Booluarte's decree has allocated approximately US$ 3.27 million towards enhancing patient care, strengthening case detection measures, and providing informative reports for the general population and healthcare workers. The emergency measures encompass the procurement of intravenous immunoglobulin and human albumin, as well as the implementation of specialized diagnostics for identifying the biological agents associated with the syndrome. Additionally, arrangements for air-assisted transportation of patients in critical or emergency conditions are being made. The official document highlights that, thus far this year, at least 18 of the country's 24 departments and one constitutional province have reported at least one case of Guillain-Barré Syndrome.
What is Guillain-Barré Syndrome?According to the National Insitute of Neurological Disorders and Stroke (NIH), Guillain-Barré syndrome (GBS) is a neurological condition characterized by an uncommon immune system response that mistakenly targets a section of the peripheral nervous system. This system comprises the network of nerves outside the brain and spinal cord. GBS can manifest in varying degrees of severity, ranging from mild cases with brief episodes of weakness to more severe instances of paralysis, potentially leading to dependence on external respiratory support. Encouragingly, the majority of individuals affected by GBS eventually experience recovery, even those facing severe paralysis. However, some individuals may continue to experience residual weakness following their recovery. In GBS, symptoms may progress gradually over a span of hours, days, or weeks, eventually rendering certain muscles nonfunctional. In
Read more on economictimes.indiatimes.com